AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
BOSTON, May 14, 2013 /PRNewswire/ — On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape.
Among the clinical trial leaders in attendance will be AG Mednet CEO Abraham Gutman who will moderate a special program about successful site leadership and disruptive technologies transforming investigator sites and challenging old assumptions among global networks.
Gutman, recently recognized by CenterWatch as one of 20 innovators changing the face of the clinical trial industry, is responsible for leading AG Mednet and its breakthrough technology that improves the quality of clinical trials by eliminating preventable and costly human errors.
For more information about AG Mednet or to schedule a conversation with Abraham Gutman about the role of disruptive technologies at clinical trial investigative sites around the world, please email email@example.com.
For more information about the Inaugural Forum on Optimizing Clinical Research Performance, please visit http://www.iibig.com/conferences/P1301/overview.html.
About AG Mednet
AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 17,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world’s top 20 pharmaceutical, biotech and medical device companies.
Dawn Sullivan or Molly Delaney
SOURCE AG Mednet